<DOC>
	<DOCNO>NCT01764360</DOCNO>
	<brief_summary>Kaposi sarcoma ( KS ) AIDS-related cancer commonly report cancer Zimbabwe . If find early , may treatable antiretroviral therapy ( ARVs ) alone improve general well-being ease care . It may also possible avoid use expensive chemotherapy KS pick early course disease . Early KS often overlook recognize health professional . The purpose study learn level medical care treatment provide primary care clinic Zimbabwe help people AIDS-KS well maintain health longer . This do monitoring KS diagnose treat primary care clinic . Clinics train recognize treat KS good identify care patient disease .</brief_summary>
	<brief_title>Strategies Improve Kaposi Sarcoma ( KS ) Outcomes Zimbabwe</brief_title>
	<detailed_description>The `` Strategies Improve Kaposi Sarcoma ( KS ) Outcomes Zimbabwe '' ( SIKO Study ) consist interventional observational component . Eight ( 8 ) primary care sit Zimbabwe randomize receive structured training Kaposi sarcoma ( KS ) diagnosis treatment . This intervention evaluate utilization three component ; KS Standardized Evaluation ( KS-SE ) , integration palliative care algorithm-based KS management strategy sit . The impact overall intervention evaluate use step-wedge randomized cluster trial design 8 primary care sit randomize receive intervention different time point intervention eventually implement site 2 year ( 102 week ) course study . The 2 year evaluation period consist monitoring period , follow intervention period . The observational component SIKO study enrollment patient find Kaposi sarcoma ( KS ) either monitor intervention period eight study site . After informed consent obtain , information HIV status , KS diagnosis staging , demographic data quality life questionnaire collect , along A glycoprotein predominantly find surface helper T cell . ( CD4+ ) count ( available ) , antiretroviral ( ARV ) medication tuberculosis KS treatment history . Patients continue follow course study .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Kaposi</mesh_term>
	<criteria>Subjects age 1 80 , Recruited eight ( 8 ) participate primary care site , Subjects newly identify Kaposi sarcoma ( KS ) HIV1 infection . None Noted</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>